Glucosamine + chondroitin

Glucosamine + chondroitin has been studied in 17 papers since 2003: 8 trials and 3 observational studies in people, 1 in animals, 4 reviews. The newest paper, Jun 24, 2025: “The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review”.

Intervention

17 papers study it28 findingsUpdated

See all 17 papers on glucosamine + chondroitin

At a glance

The findings reach people, from one lab or study. 12 independent labs in 5 countries; 11 trials, none about aging, 3 with no results posted.

“and the rate of response to combined treatment was 6.5 percentage points higher (P=0.09).”
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritisThe New England journal of medicine2006doi:10.1056/nejmoa052771

2 of its findings point the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 12 independent labs in 5 countries
  • 2 findings against
  • 11 trials, none about aging, 3 with no results posted
  • Funders: National Institutes of Health and others
  • 1 of 25 findings with company ties
  • 4 of 11 trials sponsored by its developers
  • Human trial8
  • Humans3
  • Animals1

8 studies gave glucosamine + chondroitin to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on knee osteoarthritis

Randomized trial4 weeks24 peopleBothIn knee osteoarthritis patients receiving manual therapy and resistance exercise trainingJPMA. The Journal of the Pakistan Medical Association, Jul 1, 2022

down: Decreases IL-6-9% (P=0.001, FDR<0.05)

Randomized trial6 months96 peopleBothKnee osteoarthritisAnti-inflammatory & anti-allergy agents in medicinal chemistry, Jan 1, 2020

no change: Has no effect on functional impairment

Randomized trial6 months164 peopleIn patients with symptomatic knee osteoarthritisArthritis & rheumatology (Hoboken, N.J.), Jan 1, 2017

down: Decreases C-reactive protein-23%

Randomized trial28 days20 people10 men; 10 womenaged 20–55 yearsHealthy, overweight, non-smoking adultsPloS one, Feb 26, 2015

down: Decreases joint space narrowingP < 0.0001

Randomized trial8 months80 peopleover 40 yearsMidlife adults; adult patients with Kaschin-Beck diseaseClinical rheumatology, Jan 28, 2010

What did studies of glucosamine + chondroitin find?

19

Studies of glucosamine + chondroitin measured 19 outcomes, among them inflammation, C-reactive protein and knee pain.

Inflammation

downin humans1

1 study
  1. Glucosamine + chondroitin decreases inflammation in humans.

    “With the exception of ubiquitin-mediated proteolysis, and proteins located in the nucleus, all pathways were down-regulated after G&C supplementation.”

    Human trial28 daysn = 18

    Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans

    PloS one

  2. Glucosamine + chondroitin decreases inflammation in humans (healthy, overweight) (P = 2.6 x 10-16).

    “the most significant being a reduction in the "cytokine activity" pathway (P = 2.6 x 10-16), after glucosamine and chondroitin compared to placebo.”

    Human trialhealthy, overweightglucosamine hydrochloride plus chondroitin sulfateplasma1500 mg/d + 1200 mg/d28 daysn = 18

    Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans

    PloS one

More on Inflammation

C-reactive protein

downin humans1−23%

1 study
  1. Glucosamine + chondroitin decreases C-reactive protein in humans (-23%).

    “Statistically significantly lower geometric mean CRP concentrations were observed after the G&C intervention compared to placebo (-23%, P = 0.048; ).”

    Human trial28 daysn = 18

    Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans

    PloS one

  2. Glucosamine + chondroitin decreases C-reactive protein in humans (healthy, overweight) (-23% (P = 0.048)).

    “Serum CRP concentrations were 23% lower after glucosamine and chondroitin compared to placebo (P = 0.048).”

    Human trialhealthy, overweightglucosamine hydrochloride plus chondroitin sulfateserum1500 mg/d + 1200 mg/d28 daysn = 18

    Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans

    PloS one

More on C-reactive protein

Knee pain

downin humans1no changein humans1

1 study
  1. Glucosamine + chondroitin decreases knee pain in humans (moderate-to-severe knee pain at baseline) (79.2% vs. 54.3%, P=0.002).

    “For patients with moderate-to-severe pain at baseline, the rate of response was significantly higher with combined therapy than with placebo (79.2 percent vs. 54.3 percent, P=0.002).”

    Human trialmoderate-to-severe knee pain at baseline24 weeksn = 354

    Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    The New England journal of medicine

  2. Glucosamine + chondroitin showed no clear effect on knee pain in humans (overall) (+6.5 percentage points, P=0.09).

    “and the rate of response to combined treatment was 6.5 percentage points higher (P=0.09).”

    Human trialoverall24 weeksn = 1,583

    Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    The New England journal of medicine

Adverse effects

downin humans1

1 study
  1. Glucosamine + chondroitin decreases adverse effects in humans (osteoarthritis and joint pain) (minimal or no adverse effects).

    “most safety studies indicating minimal or no adverse effects.”

    Reviewosteoarthritis and joint pain

    The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review

    Nutrients

Osteoarthritis

downin humans1

1 study
  1. Glucosamine + chondroitin decreases osteoarthritis in humans (osteoarthritis and joint pain) (over 90% of efficacy studies reporting positive outcomes).

    “glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.”

    Reviewosteoarthritis and joint pain

    The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review

    Nutrients

More on Osteoarthritis

Allergic reaction

upin humans1

1 study
  1. Glucosamine + chondroitin induces allergic reaction in humans (lumbar degenerative joint disease).

    “she developed an itchy rash on her torso and legs. Over the next few hours, the rash spread over her entire body, and facial swelling developed.”

    Human triallumbar degenerative joint diseasepillsfemales

    Delayed Skin Allergy to Glucosamine Chondroitin Supplement

    Cureus

Knee osteoarthritis

no changein humans1

1 study
  1. Glucosamine + chondroitin showed no clear effect on knee osteoarthritis in knee osteoarthritis patients receiving manual therapy and resistance exercise training.

    “glucosamine and chondroitin sulfate supplementation for 4 weeks showed no additional benefits.”

    Human trialin knee osteoarthritis patients receiving manual therapy and resistance exercise training4 weeksn = 24

    Effects of glucosamine and chondroitin sulfate supplementation in addition to resistance exercise training and manual therapy in patients with knee osteoarthritis: A randomized controlled trial

    JPMA. The Journal of the Pakistan Medical Association

More on Knee osteoarthritis

Colorectal serrated polyp

no changein humans1

1 study
  1. Glucosamine + chondroitin was not clearly linked with colorectal serrated polyp in humans.

    “No associations were observed for serrated polyps.”

    Humans

    Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Colorectal serrated polyp

Colorectal adenoma

no changein humans1OR 1

1 study
  1. Glucosamine + chondroitin was not clearly linked with colorectal adenoma in humans (NHS2) (OR = 1.00; 95% CI, 0.86-1.17).

    “overall conventional adenoma: OR = 1.00; 95% CI, 0.86-1.17”

    HumansNHS2

    Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Colorectal adenoma

IL-6

downin humans1

1 study
  1. Glucosamine + chondroitin decreases IL-6 in humans (knee osteoarthritis) (-9% (P=0.001, FDR<0.05)).

    “Serum IL-6 was significantly reduced (by 9%, P=0.001) after GH+CS, and satisfied the FDR<0.05 threshold.”

    Human trialknee osteoarthritisserum1500 mg GH + 1200 mg CS daily6 monthsn = 96

    Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients

    Anti-inflammatory & anti-allergy agents in medicinal chemistry

More on IL-6

Functional impairment

no changein humans1

1 study
  1. Glucosamine + chondroitin showed no clear effect on functional impairment in patients with symptomatic knee osteoarthritis.

    “Both placebo treatment and CS/GS combination treatment improved to a similar extent the total WOMAC score as well as the pain and function WOMAC subscale scores”

    Human trialin patients with symptomatic knee osteoarthritisCS 1,200 mg plus GS 1,500 mg daily6 monthsn = 164

    Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Arthritis & rheumatology (Hoboken, N.J.)

Joint space narrowing

downin humans1

1 study
  1. Glucosamine + chondroitin decreases joint space narrowing in humans (adult patients with Kaschin-Beck disease) (P < 0.0001).

    “Knee joint space of the experimental group narrowed slowly compared to the control group.”

    Human trialadult patients with Kaschin-Beck diseaseoral mixtureknee joint1,600 mg twice daily8 monthsn = 80

    Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease

    Clinical rheumatology

Balance

downin humans1

1 study
  1. Glucosamine + chondroitin impairs balance in humans (knee osteoarthritis) (approximately a 10% difference).

    “balance was better in the placebo group with approximately a 10% difference compared to the GH/CS group.”

    Human trialknee osteoarthritis1500/1200mg12 months

    Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study

    Osteoarthritis and cartilage

Mobility

no changein humans1

1 study
  1. Glucosamine + chondroitin showed no clear effect on mobility in humans (knee osteoarthritis).

    “There were also no significant differences between the groups in 6-min walk or knee strength”

    Human trialknee osteoarthritis1500/1200mg12 months

    Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study

    Osteoarthritis and cartilage

Physical function

no changein humans1

1 study
  1. Glucosamine + chondroitin showed no clear effect on physical function in humans (knee osteoarthritis).

    “WOMAC function and pain did not differ significantly between the groups at 6- or 12-month follow-up.”

    Human trialknee osteoarthritis1500/1200mg12 months

    Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study

    Osteoarthritis and cartilage

All 19

What is glucosamine + chondroitin linked with?

6

Studies link glucosamine + chondroitin with 6 measures, among them colorectal adenoma, high-risk colorectal adenoma and cardiovascular mortality.

Colorectal adenoma

downin humans1OR 0.9

1 study
  1. Glucosamine + chondroitin is linked with a lower risk of colorectal adenoma in humans (pooled NHS and HPFS) (10% lower risk (OR = 0.90; 95% CI, 0.81-0.99)).

    “10% (OR = 0.90; 95% CI, 0.81-0.99; P heterogeneity = 0.36) lower risk of high-risk adenoma and overall conventional adenoma, respectively”

    Humanspooled NHS and HPFS

    Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Colorectal adenoma

High-risk colorectal adenoma

downin humans1OR 0.74

1 study
  1. Glucosamine + chondroitin is linked with a lower risk of high-risk colorectal adenoma in humans (pooled NHS and HPFS) (26% lower risk (OR = 0.74; 95% CI, 0.60-0.90)).

    “glucosamine + chondroitin use at baseline was associated with a 26% (OR = 0.74; 95% CI, 0.60-0.90; P heterogeneity = 0.23)”

    Humanspooled NHS and HPFS

    Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on High-risk colorectal adenoma

Cardiovascular mortality

downin humans1HR 0.42

1 study
  1. Glucosamine + chondroitin is linked with a lower risk of cardiovascular mortality in humans (HR = 0.42; 95% CI, 0.23-0.75).

    “CVD mortality, HR = 0.42; 95% CI, 0.23-0.75”

    Humansa year or longern = 16,686

    Glucosamine/Chondroitin and Mortality in a US NHANES Cohort

    Journal of the American Board of Family Medicine : JABFM

Mortality

downin humans1HR 0.73

1 study
  1. Glucosamine + chondroitin is linked with a lower risk of mortality in humans (HR = 0.73; 95% CI, 0.57-0.93).

    “Multivariable-adjusted HR showed that the association was maintained after adjustment for age, sex, race, education, smoking status, and physical activity (all-cause mortality, HR = 0.73; 95% CI, 0.57-0.93”

    Humansa year or longern = 16,686

    Glucosamine/Chondroitin and Mortality in a US NHANES Cohort

    Journal of the American Board of Family Medicine : JABFM

Osteoarthritis pain

mixedin humans1

1 study
  1. Glucosamine + chondroitin is associated with osteoarthritis pain in humans (osteoarthritis).

    “The findings of these studies are mixed, owing in some cases to the high rate of placebo response added to by the ethical incorporation of rescue analgesics”

    Reviewosteoarthritis

    Glucosamine and Chondroitin Sulfate: What Has Been Learned Since the Glucosamine/chondroitin Arthritis Intervention Trial

    Orthopedics

Colorectal cancer

downin humans1HR 0.55

1 study
  1. Glucosamine + chondroitin is linked with a lower risk of colorectal cancer in humans (use on 4+ days/week for 3+ years) (HR: 0.55; 95 % CI 0.30-1.01).

    “Persons reporting use of glucosamine + chondroitin on 4+ days/week for 3+ years had a non-statistically significant 45 % lower CRC risk than non-users (HR: 0.55; 95 % CI 0.30-1.01; p-trend: 0.16).”

    Humansuse on 4+ days/week for 3+ years3+ yearsn = 75,137

    Use of glucosamine and chondroitin supplements and risk of colorectal cancer

    Cancer causes & control : CCC

More on Colorectal cancer

Has glucosamine + chondroitin been tested in people?

0 of 11 about aging

Yes: 8 trials and 3 observational studies in people have been published, and 10 trials are registered.

In trials

Trial sponsors

Latest

See all 17 papers on glucosamine + chondroitin